| Agenda at a GlanceAgenda at a GlanceFull Day Symposium | Half Day Workshop | CMS Dispute Resolution Meeting | Conference Day 1 | Conference Day 2 Full Day Symposium | Monday September 21, 2009 |
B1
After the Final DRA Rule, Now What? | | 8:15 | Symposium Registration and Morning Coffee | | 9:00 | Chairperson’s Welcome
Pam Vaal, Independent Consultant, Formerly Eli Lilly & Company (Retired) | | 9:15 | Calculation Methodology: Obtain Clear Answers to Your Most Pressing Rebate Methodology Questions, including:
Robert Ririe, Senior Principal, IMS Managed Markets Services
John Glover, Principal, IMS Managed Markets Services | | 10:30 | 30-Minute Networking Break | | 11:00 | Process and Operational Answers for Post DRA Methodology Questions
Miree Lee, MS, MBA, Pharma/Biotech Pricing & Contracts Consultant, M. Lee Consulting, LLC Ben Martin, Epstein Becker and Green | | 12:00 | Networking Luncheon | | 1:30 | Government Pricing & Medicaid Rebate Processing Using SAP Solutions
Sanjay Shah, President CEO, Chief Architect, VISTEX | | 2:00 | Best Practices and Considerations to Complement Your GP Solution
Christopher Cobourn, Government Program, Practice Lead, Compliance Implementation Services
Chrissy Spicer, Compliance Specialist, Compliance Implementation Services | | 3:00 | 30-minute Afternoon Networking Break | | 3:30 | Evaluating the Current GP Environment
Moderator:
Christopher Cobourn, Government Program, Practice Lead, Compliance Implementation Services
Panelists:
Catrina Hirschauer, National Account Manager, Xanodyne Pharmaceuticals Brian McCartney, JNJ
Katie Lapins, Compliance Implementation Services
Todd LeDuc, Senior Government Sales Analyst, Contract Pricing & Reimbursement, Solvay Pharmaceuticals, Inc. Randy Colvin, Sr. Director Corporate Accounts, Allos tTerapeutics | | 5:00 | Symposium Concludes |
|
Back to top| Half Day Workshop | Monday September 21, 2009 |
B2
Medicaid Drug Rebate Program Fundamentals – Building the Unity Between Products, Pharmacy, Policy and Operations | 1:00 | Registration | 3:00 | 30-Minute Refreshment Break | | 1:30 | Workshop Begins | 5:00 | Workshop Concludes |
The Medicaid Drug Rebate Program can be a complicated endeavor to any pharmaceutical manufacturer. It is a program that works best when all components are properly “connected” in the drug delivery industry. How one goes about making this connection and why it is so important is the topic of this workshop, also known as the Medicaid Drug Rebate Program 101. Whether you’re new to the Medicaid Drug Rebate Program, need a refresher course, or would just like to increase your knowledge, this workshop is your solution. Come and network and build your knowledge about Medicaid rebates and the drug delivery industry. This is one of the rare workshops offered that allows participants the opportunity to experience trainers from a manufacturer, a state Medicaid, and the pricing compendia. Pharmaceutical Manufacturer: - Review a brief history of OBRA ’90 and ’93 legislation
- Introduce and understand a product in the industry (internally and externally)
- Understand Medicaid rebate roles and responsibilities within a pharmaceutical manufacturer
- Review the processing of rebates as it currently exists
- Understand the role of the pharmacy and identifying players in the drug delivery industry
- Learn how to reduce disputes
- Balance timelines and maximize internal efficiencies
- Obtain lessons learned
| State Medicaid Officials: - Gain an understanding of how a state places a product in their system
- Learn about formularies and how policies are created
- Learn how rebate invoices are generated and how disputes are handled
- Receive important processing hints to a pharmaceutical manufacturer: What works, what doesn’t work, and follow the rebate checks after you put it in the mail
- Explore future improvements and /or challenges in the rebate arena
|
The focus is on pharmaceutical manufacturers and the basic understanding of how a product begins, grows and is maintained in the Medicaid Rebate Program. Emphasis is placed on understanding all the “players” in the industry and the crucial component of understanding a product. As we move toward supplemental programs being introduced, it is essential that we not forget about the basics and the importance in making the necessary connections to be most successful in the reporting of products within the Medicaid Drug Rebate Program. Failure to report correctly will have a profound effect on many other programs introduced and can impact the reimbursement of your products. NCPDP:
Learn how to partner and understand how the NCPDP can achieve data uniformity and reliability through standardization in the Medicaid Drug Rebate Program. Connect through standardization, a common language and understanding by all associated within the healthcare delivery industry. Gain a better understanding of: - NDC numbers
- Products: Sold versus dispensed
- NCPDP Workgroup #2 Product Identification (Quick Form) available
| Who Should Attend
This workshop is designed for all professionals in the Pharmaceutical, Biotechnology, industries as well as state government officials who are involved with: - Medicaid Rebate Manager, Directors, Analysts, Associates
- Government Contracts, Operations and Public Policy
- General Chief Counsel/Legal
- Compliance Officers
- Pharmacy Advisors
- Accounting/Finance
- IT / IS
|
Workshop Leaders:
Linda L. Schock, Associate Director, CV Therapeutics
Kay Morgan, Vice President, Drug Product Pricing, Gold Standard
Heather Murphy, Manager, Pharmacy Contracts and Rebates, Medicaid CHIP Program Operations, Texas Health & Human Services Commission |
|
Back to top| CMS-Moderated Dispute Resolution Service | Monday September 21, 2009 |
8:30- 12:00
Facilitated by:
Tamara Bruce, Technical Director, CMS Medicaid Drug Rebate Team For the sixth year running, IIR’s Summit on the MDRP offers a morning opportunity for dispute resolution between states and manufacturers, moderated and facilitated where needed by dispute resolution professionals from CMS. Sign up for 30-minute private sessions that enable you to address outstanding issues or, if you have no dispute, take this opportunity for face-to-face communication with your state or manufacturer counterpart. If you need technical assistance please contact:
Anne Reel, Program Director areel@iirusa.com or 919-676-0306. |
|
Back to top | Conference Day One | Tuesday September 22, 2009 |
| 7:30 | Registration and Morning Coffee | | 8:15 | Chairperson Welcome & Industry Introduction
Edward J McAdam, Senior Director, Contracting, Pricing & Analytics, DAIICHII SANKYO PHARMA | POLITICAL LANDSCAPE | | 8:30 | Solving the Healthcare Crisis from the Architect of Obama’s Healthcare Reform
Senator Tom Daschle Former Senate Majority and Minority Leader | | 9:30 | Impact of New Federal Administration on Pharmaceutical Industry
Alice Valder Curran, Partner, HOGAN & HARTSON | | 10:15 | Refreshment and Networking Break in Exhibit Hall | INFLUENCE THE POLICY MAKERS | | 10:45 | Current CMS Policy Initiatives and a Retrospective of DRA Policy Decisions
Kim Howell, Senior Drug Policy Analyst, Centers for Medicare and Medicaid Services (CMS) | DIRECT CMS ACCESS! | | 11:30 | Current CMS Rebate Data, Operations and Technical/Systems Updates
Tamara Bruce, Technical Director, CMS Medicaid Drug Rebate Team
Diane Dunstan, Lead RO DRP and Medicaid Drug Rebate Analyst, Denver Regional Office, CMS
Dona Coffman, Technical Director, Division of Information Analysis and Technical Assistance, CMS | | 12:15 | Networking Luncheon |
|
| Track | Track A
Medicaid Rebate Operations for Manufacturers | Track B
340B and Other Public Sector Reimbursement Programs | | 1:30 | Chairperson’s Opening Remarks
William Baxter, Strategic Advisor, Government Affairs, CIS, Former Director, Rebate Management, JOHNSON & JOHNSON (retired) | Chairperson’s Opening Remarks
John Bliss, Manager, Contract Management, Graceway Pharmaceuticals | | 1:35 | Medicaid Payment Process Improvement – Avoid Pitfalls and Duplicate Discounts
William Baxter, Strategic Advisor, Government Affairs, CIS Former Director, Rebate Management, JOHNSON & JOHNSON (retired)
Ramie Zomisky, Rebate Analyst, formerly Amylin
Catrina Hirschauer, National Account Manager, Xanodyne Pharmaceuticals Inc Cindy Salfrank, Cephalon | Updates for the 340B Program: New Information on Price Reporting, Membership Management and Cross Walking Christopher A. Hatwig, M.S., R.Ph., FASHP, Vice President, Apexus/340B Prime Vendor Program | | 2:15 | Getting Together–Successful Dispute Resolution Best Practices
Kris Flynn, Medicaid Analyst, Wockhardt/MORTON GROVE PHARMACEUTICALS
Tom Simonson, Manager, Drug Rebate Program, Oklahoma Health Care Authority | Pharmacy Affairs Database Interactive Tour
Sharley Chen, Independent Consultant | | 3:00 | 30-Minute Afternoon Networking Break | | 3:30 | Vigilant Auditing and Monitoring Practices and Procedures
Lorraine Moccio, Director, Government Pricing Analytics, Johnson & Johnson
Jim Jaakobs, Manager, Internal Audit, Johnson & Johnson
Lisa Kiniklis, Senior Manager, Government Pricing & Reporting, BIOGEN IDEC
Clarissa Crain, Senior Compliance Specialist, COMPLIANCE IMPLEMENTATION SERVICES | Legislative Updates & 340B Pricing Structure Updates
William Von Oehsen, President, SAFETY NET HOSPITALS FOR PHARMACEUTICAL ACCESS | | 4:15 | Understanding and Operationalizing the Differences in the Various Government Price Calculations
David Iuliani, Senior Director Government & Pricing Systems, Sanofi-Aventis
Jay McKinley, Director, Contract Operations, Cephalon
Ben Martin, Epstein Becker and Green
Constance Wilkinson, Epstein Becker and Green | Track Concludes | 5:00 Day One Concludes • 5:00-6:00 Networking Reception |
| Track | Track C
State Reporting Requirements | Track D
Compliance with State and Federal Guidelines | | 1:30 | Chairperson’s Opening Remarks
Mary Kay Owens RPh, CPh, President, Southeastern Consultants | Chairperson’s Opening Remarks
Pam Vaal, Independent Consultant, Formerly ELI Lilly and Company (retired) | | 1:35 | State Price Reporting Requirements
Sherry Montoya, Benefits Bureau State of New Mexico
Danielle Drissel, Associate, HOGAN & HARTSON LLP
| A Strategic and Operational View of the Government as a Customer
Christopher Cobourn, Government Program, Practice Lead, COMPLIANCE IMPLEMENTATION SERVICES | | 2:15 | Strategies for Handling SPAPS/ADAPs/SCHIP and Other State Programs Ellen Todesca Arca, EDC Conneticutt | Average Wholesale Price (AWP)–Past, Present and Future
Wayne Gibson, Managing Director/ Forensic and Litigation Consulting, FTI Consulting | | 3:00 | 30-Minute Afternoon Networking Break | | 3:30 | Seeing Over the Fence – How the Reimbursement Works on the State’s Side
Sharon Greeson, Pharmacy Program Manager, EDS North Carolina Medicaid Karen Kluczykowski, Director, EDS KANSAS
| Generic Companies Navigating the MDRP
Paula J. Grist, Senior Director, Government Programs & Pricing Compliance, Wockhardt U.S.A.
Frank Prybeck, Director, Sandoz
Annamarie Lee, Associate Director of National Contract Sales, Customer Service, Upsher-Smith Laboratories | | 4:15 | State Reporting Requirements John Shakow, Partner, KING & SPAULDING | At the Crossroads of 'Change' - Why Tricare, Discount Reallocation and the 2010 Budget mandate a new approach to pharmaceutical planning and forecasting capabilities
Ali Tore, Vice President of Product Management, Model N | 5:00 Day One Concludes • 5:00-6:00 Networking Reception |
Back to top | Conference Day Two | Wednesday September 23, 2009 |
| 8:00 | Morning Coffee | | 8:15 | Chairpersons Recap of Day One
Edward J. McAdam, Director, Contract Administration, DAIICHII SANKYO PHARMA | | 8:30 | Current Status of AMP Reimbursement Litigation and the First DataBank/Medispan Average Wholesale Price AWP Settlements
Don L. Bell, II, Senior Vice President and General Counsel, NATIONAL ASSOCIATION OF CHAIN DRUG STORES | | 9:15 | Improve Management of Veterans Affairs Pricing Compliance Mark Myers, Director, Office COntract Review, Department f Veterans Affairs | | 9:45 | Specific Operational Changes From New Tricare Regulation
Moderator:
Tim Nugent, Managing Director/Forensic & Litigation Consulting, FTI Consulting
Panelists:
Jay McKinley, Director, Contract Operations, Cephalon Constance Wilkinson, Epstein Becker and Green | | 10:30 | 30-Minute Morning Networking Break | | 11:00 | Improve Corporate Compliance with Current Civil and Criminal Enforcement Activities
Viveca D. Parker, Assistant United States Attorney, UNITED STATE DEPARTMENT OF JUSTICE, USDOJ
Mike Theis, Partner, HOGAN & HARTSON | | 11:45 | Health Care Reform: A Renewed Focus on Coordination and Continuity of Care to Achieve Cost Efficiency and Improved Quality
Mary Kay Owens RPh, CPh, President, Southeastern Consultants | | 12:15 | Networking Luncheon |
|
| Track | Track A
Medicaid Rebate Operations for Manufacturers | Track B
340B and Other Public Sector Reimbursement Programs | | 1:30 | Chairperson’s Opening Remarks
William Baxter, Strategic Advisor, Government Affairs, CIS Former Director, Rebate Management, JOHNSON & JOHNSON (retired) | Chairperson’s Opening Remarks
John Bliss, Manager, Contract Management, Graceway Pharmaceuticals | | 1:35 | In House Counsel Perspective on Pricing Issues and Importance of Pricing Committees
William C. Waller, Associate General Counsel, Regulatory Affairs, Medicis Pharmaceutical Corporation | Successful Rebate Processing with NCPDP Standardization
Dan Hardin, R.Ph., M.B.A. Senior Vice President, Public Sector & Resident Care Management, SXC Health Solutions, Inc. | | 2:15 | Complying with the Changing Government Programs Environment-Process Efficiencies
Panelist:
Marijo Bustos, Government Business Analyst, National Accounts Administration, APP Pharmaceuticals
Michael Hepburn, Controller, Government Contract Compliance, ORTHO-MCNEIL JANSSEN PHARMACEUTICAL SERVICES Ali Tore, MODELN |
| | 3:00 | Conference Concludes-See You Next Year! |
| Track | Track C
State Reporting Requirements | Track D
Compliance with State and Federal Guidelines
*This track is not ACPE-accredited | | 1:30 | Chairperson’s Opening Remarks
Mary Kay Owens RPh, CPh, President, Southeastern Consultants | Chairperson’s Opening Remarks
Pam Vaal, Independent Consultant, Formerly, ELI Lilly and Company (retired) | | 1:35 | Best Practices for Managing J Code Billing
Tom Simonson, Manager, Drug Rebate Program, Oklahoma Health Care Authority Cindy Laclair, Rebates, EDS KANSAS | Prescription for change: Adapting to the new Healthcare
Katherine Buckley, Director, PricewaterhouseCoopers
Erinn Hutchinson, Director, PricewaterhouseCoopers | | 2:15 | States and Manufacturer’s to Streamline Relationships
Karen Kluczykowski, Director, EDS KANSAS
Cindy Laclair, Rebates, EDS KANSAS | Negative Pricing: When Statutory Discounts Create a Government Profit Center
John Shakow, Partner, KING AND SPAULDING | | 3:00 | Conference Concludes-See You Next Year! |
|
